Orchid Mediservices And Research Profile
Key Indicators
- Authorised Capital ₹ 4.00 Cr
as on 30-06-2024
- Paid Up Capital ₹ 4.00 Cr
as on 30-06-2024
- Company Age 14 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.75 Cr
as on 30-06-2024
- Satisfied Charges ₹ 1.48 Cr
as on 30-06-2024
- Revenue 75.30%
(FY 2021)
- Profit 182.15%
(FY 2021)
- Ebitda 32965.37%
(FY 2021)
- Net Worth 14.93%
(FY 2021)
- Total Assets 4.04%
(FY 2021)
About Orchid Mediservices And Research
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.00 Cr and a paid-up capital of Rs 4.00 Cr.
The company currently has active open charges totaling ₹2.75 Cr. The company has closed loans amounting to ₹1.48 Cr, as per Ministry of Corporate Affairs (MCA) records.
Manish Bhatnagar, Valay Solanki, Manish Gandhi, and Three other members serve as directors at the Company.
- CIN/LLPIN
U73200GJ2010PTC060272
- Company No.
060272
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Apr 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Orchid Mediservices And Research?
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manish Gandhi  | Director | 01-Nov-2017 | Current |
| Manish Bhatnagar | Director | 15-Apr-2010 | Current |
| Valay Solanki | Director | 01-Nov-2017 | Current |
| Chitrarekha Bhatnagar | Director | 28-May-2018 | Current |
| Suraj Bhatnagar | Director | 28-May-2018 | Current |
| Rupesh Shah | Director | 11-Mar-2023 | Current |
Financial Performance of Orchid Mediservices And Research.
Orchid Mediservices And Research Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 75.3% increase. The company also saw a substantial improvement in profitability, with a 182.15% increase in profit. The company's net worth Soared by an impressive increase of 14.93%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Orchid Mediservices And Research?
In 2021, Orchid Mediservices And Research had a promoter holding of 75.53% and a public holding of 24.47%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vasudev Ginning & Pressing Private LimitedActive 12 years 10 monthsValay Solanki is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 12 Feb 2021 | ₹2.75 Cr | Open |
Yes Bank Limited Creation Date: 10 Jan 2017 | ₹1.48 Cr | Satisfied |
How Many Employees Work at Orchid Mediservices And Research?
Orchid Mediservices And Research has a workforce of 14 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Orchid Mediservices And Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Orchid Mediservices And Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
